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EDITORIAL 
POLYPHARMACY VERSUS DRUG COMBINATIONS 
Drug combinations have been known to be used either for increasing effcctivity 
or for decreasing side-efFects. It is only when multiple drugs are prescribed without 
adequate scientific evidence in their favour then such practices need careful scrutiny. 
Multiple drug use in psychiatry has recently gained currency and so require thoughtful 
consideration. The term polypharmacy is generally used to denote such practices. 
Combinations of neuroleptics, anticholinergics, antidepressants and anxiolytics have 
become widely prevalent. Interestingly enough, large number of practitioner' use 
combination of more than one neuroleptic or antidepressant for which there is hardly 
any justification. Such practices have led to the extensive manufacturing of drug com-
binations by a large number of pharmaceutical houses in this country. 
Since the situation does exist and before it takes a serious magnitude, it is impera-
tive to consider the motivations for polypharmacy and Us benefits and ill-effects. 
Some of the main motives underlying the use of polypharmacy could be (a) psychologi-
cal insecurity of the therapist in prescribing single drug lest the patient may feel 
dissatisfied with a short prescription; (b^ drug use is purely symptom-based; and 
(c) certain therapeutic situations rationally needing a drug combination. 
Commonest drug combination used in psychiatry is that of neuroleptics and 
anticholinergics. This practice appears to be so widespread that the Heads of WHO 
Centres of Biological Aspects of Mental Illness formulated a consensus statement that 
"the prophylactic use of anticholinergics in patients on neuroleptic treatment is not 
recommended, and may be justified only early in treatment (after which it should be 
discontinued and its need should be re-evaluated)." This statement has however, not 
met universal acceptance as many investigators feel that the withdrawal of anticho-
linergic in some of the patients leads to re-emergence of extra pyramidal symptoms. 
Use of antidepressants in schizophrenia is another area which is riddled with 
controversies. Many authors feel that addition of antidepressants helps in relieving 
depression while most of the well-designed studies did not show any significant benefit 
by such combination. However, the role of anxiolytics in combinations with neurolep-
tics is being studied afresh and as yet no definite conclusion has emerged. 
As regards the management of depression, the combination of anxiolytics and 
antidepressant drugs are being commonly used. Such combinations may be more 
justified in patients presenting with severe anxiety and agitation. Moreover, in cer-
tain depressive conditions combinations are especially useful; for instance, neuroleptics 
and antidepressants could be drugs of choice in cases of delusional depression. Likewise, 
combination of trycyclics and M \0 has been found effective in resistant depression. 
Regardless of the above scientific observations and clinical impressions one lias 
also to take into consideration the psychosocial realities of the country before taking a 
dogmatic stand on these issues. For instance, majority of psychotics are treated as 
out-patients and often belong to distant places and if one witiihole's anticholinergics, 
emergence of extra pyramidal side effects may ultimately lead to discontinuation of 
treatment. Similarly, often the use of fixed drug combination is viewed with contempt. 2  A. K. AGARWAL 
But if an illiterate is given neuroleptic and anticholinergic separately i*. is quite likely 
that lie may take just one of the two drugs either due to incomplete comprehension of 
instructions or due to (ear of taking too many allopathic drugs. The latter may prompt 
him to experiment with single drug which might ultimately lead to either side-effects 
or trcatn t nt fuilurc. 
To co. elude one may state that the field of drug combinations in psychiatry 
requires much careful evaluation. For instance, the newer antidepressants whose 
mechanisms of action are complimentary to each other may need evaluation ol their 
eli'ectivity and toxicity when presented together. In this contt xt it may also be added 
that any irrational or unscientific use of drug eominations should be frowned upon. 
Quite often some therapists get misled by the use of such combinations in just one or 
two patients where the recovery might be purely coincidental. Such kind of unscien-
tific observations may lead to a faulty clinical practice. 
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